Non-malignant haematology clinical trials - Peter MacCallum Cancer Centre

If you would like to be considered for a clinical trial you will require a referral from your current treating team. Visit the Joining a Clinical Trial page for referral information.

For more information on non-malignant haematology clinical trials, get in contact with our Haem A team This email address is being protected from spambots. You need JavaScript enabled to view it..

Open and Recruiting Clinical Trials

VAYHIT2

A Phase 3 Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) Who Had an Insufficient Response or Relapsed After First Line Steroid Treatment

Trial ID

NCT05653219

Cancer type

Primary immune thrombocytopenia

Status

Open and recruiting

Phase

Phase three: A phase three clinical trial follows a phase two, in a larger group of patients with specific cancer types. The aim of a phase three is to compare the new treatment to existing treatments available for that cancer type

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial.

For full inclusion / exclusion criteria refer to ClinicalTrials.gov.

If you don’t find what you are looking for or would like a center closer to home that may also provide similar clinical trials, refer to the Victorian Cancer Trials Link or Australian Clinical Trials Registry.